Japanese drug maker Takeda has entered into collaboration with Massachusetts biotech Moderna to bring 50 million doses of its mRNA-based COVID-19 shots to Japanese shores. Takeda will import and distribute mRNA-1273 starting in the first half of 2021, besides handling local regulatory approvals. Moderna’s vaccine is currently undergoing a 30,000-patient …

In May 2020, the US Environmental Agency approved production of the genetically engineered, male Aedes aegypti mosquitoes, known as OX5034, by British-based, US-operated company Oxitec. This species of mosquitoes are known to spread deadly diseases like dengue, Zika, chikungunya, and yellow fever. On August 18, 2020, Florida Keys Mosquito Control …